ArticleJournal of gastrointestinal oncology2025

Effects of anlotinib combined with camrelizumab and chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma on tumor immune microenvironment.

Mingfang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.